All research
Oxytocin 2019-05-08 ClinicalTrials

Dyadic Psychotherapy Intervention Aims to Improve Postpartum Depression, Mother-Child Bonding, and Oxytocin Levels

Relationship-Based Intervention for Post-Partum Depression

Background

Post-Partum Depression (PPD) significantly impacts maternal well-being and the critical early mother-child relationship. Current standard-of-care often focuses solely on maternal symptoms, potentially overlooking the crucial dyadic interaction. Early psychosocial deprivation, such as institutional care, is known to have long-term effects on social and caregiving functioning, highlighting the importance of early intervention. Oxytocin (OT) is a key neuroendocrine modulator of affiliative behavior and stress, making it a relevant biomarker for assessing the biological underpinnings of bonding and emotional regulation in this context. This study addresses the gap by integrating dyadic therapy with biomarker assessment.

Study Design

Investigators developed a short-term dyadic psychotherapy intervention for mothers diagnosed with Post-Partum Depression and their babies within the first year of life. The study plans to assess 300 mothers using the Edinburgh Post Partum Depression Scale (EPDS) at 6 weeks, 24 weeks, and 48 weeks after delivery to identify and monitor depressive symptoms. The intervention focuses on improving the mother-child relationship. The primary endpoints include changes in maternal depressive symptoms, the quality of the mother-child relationship, and maternal and infant oxytocin levels. No specific dosage or frequency for the psychotherapy is detailed in the abstract, but it is described as a 'short-term' intervention.

Results

This abstract describes the design and hypothesized outcomes of a planned study, rather than presenting actual results. The investigators believe that following the dyadic intervention, mothers will show improvement in depressive symptoms. They also hypothesize that the quality of the mother-child relationship will improve significantly. Furthermore, a key anticipated finding is that both maternal and infant oxytocin levels will rise, suggesting a biological correlate to the observed behavioral and psychological improvements. The study aims to measure maternal stress using the EPDS at multiple time points (weeks 6, 24, and 48 post-delivery) to track changes in depressive symptoms.

The core hypothesis is that this dyadic intervention will lead to measurable improvements in maternal depression, relationship quality, and a concurrent increase in oxytocin levels in both mothers and infants. While no specific numerical results or p-values are available from this abstract, the design outlines a comprehensive approach to assess the multifaceted impact of the intervention across psychological, relational, and neuroendocrine domains. The study design emphasizes the importance of breastfeeding as a crucial experience for physical, biological, and affective development, which may be supported by improved maternal-infant bonding.

Key Findings

  • Anticipated improvement in maternal depressive symptoms following dyadic psychotherapy.
  • Expected enhancement in the quality of the mother-child relationship.
  • Hypothesized increase in maternal oxytocin levels post-intervention.
  • Hypothesized increase in infant oxytocin levels post-intervention.

Why It Matters

If the hypothesized outcomes are confirmed, this research could significantly shift the paradigm for PPD treatment from individual to dyadic care, emphasizing the mother-child unit. For clinicians, it would provide evidence for integrating relationship-based therapies alongside traditional maternal depression treatments, potentially leading to more holistic and effective interventions. For mothers and infants, improved bonding and reduced maternal depression could have profound long-term developmental benefits. The measurement of oxytocin levels offers a potential biomarker for treatment efficacy, moving beyond subjective reports. While this is a study design, successful completion could pave the way for standardized dyadic therapy protocols, offering a new avenue for supporting families in the critical first year of life.


postpartum depression dyadic therapy mother-child bonding oxytocin clinical trial design maternal health
Source: clinicaltrials:NCT04193462 · Ingested 2026-06-10 · Digest: gemini-2.5-flash